Results showed cirrhosis related parkinsonism in nine of 214 patients (4.2%), SPECT showed decreased DAT and decreased D2 receptor availability. Temporary response to levodopa was 50%, 50% did not even respond to a liver transplant. The gene discussed is SLC6A3; the disease is Parkinson disease.